Literature DB >> 7776390

An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes.

T Furukawa1, S Koumi, Y Sakakibara, D H Singer, H Jia, C E Arentzen, C L Backer, J A Wasserstrom.   

Abstract

Lidocaine is a Na+ channel blocker that is highly effective for the treatment of ventricular tachyarrhythmias, but is largely ineffective against atrial arrhythmias. If is not known if this differential efficacy is the result of differences in lidocaine inhibition of atrial v ventricular Na+ channels. The purpose of the present study was to characterize lidocaine block of Na+ channels in human atrium and ventricle. We used the whole cell voltage clamp technique with low external and internal Na+ concentrations (5 mM) to study the Na+ current (INa) in single human atrial and ventricular cells isolated enzymatically from specimens obtained during surgery. We found that tonic block of peak INa by lidocaine (200 microM, holding potential = -140 mV, 0.1 Hz, at 17 degrees C) was not voltage dependent in either cell type. Reduction of maximal peak Na+ conductance in 41 atrial cells (19.8 +/- 2.7%) and nine ventricular cells (22.6 +/- 1.7%) was virtually identical. The rate of onset of block development was determined during depolarization to either -80 mV or -20 mV. The time course of onset of block was described by a single exponential at -80 mV and by a double exponential at -20 mV. When the rate of block onset during a single conditioning depolarization was compared to that which developed during conditioning by a train of brief pulses (3 ms, 30 Hz), onset was faster during the pulse train. The results were nearly identical for atrial and ventricular INa. The time constants of recovery from block following either single pulse or multiple-pulse conditioning did not differ. These data suggest that lidocaine binds to both the activated and inactivated states of the human cardiac Na+ channel. Using an analytical method based upon the Guarded Receptor Hypothesis, we calculated apparent rate constants describing lidocaine's interaction with the three primary states of the human Na+ channel (resting, activated and inactivated). Rate constants were similar to those reported for other mammalian species. Our results demonstrate that lidocaine block of INa is virtually identical for human atrial and ventricular cells; thus additional mechanisms must be invoked to explain the differential efficacy of lidocaine against ventricular as compared to atrial dysrhythmias.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7776390     DOI: 10.1016/0022-2828(95)90090-x

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  Pharmacological management of neuropathic pain.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Functional Characterization of Human Stem Cell-Derived Cardiomyocytes.

Authors:  Glenn E Kirsch; Carlos A Obejero-Paz; Andrew Bruening-Wright
Journal:  Curr Protoc Pharmacol       Date:  2014

3.  Blocking effect of methylflavonolamine on human Na(V)1.5 channels expressed in Xenopus laevis oocytes and on sodium currents in rabbit ventricular myocytes.

Authors:  Xin-rong Fan; Ji-hua Ma; Pei-hua Zhang; Jun-lian Xing
Journal:  Acta Pharmacol Sin       Date:  2010-02-22       Impact factor: 6.150

4.  Differences between outward currents of human atrial and subepicardial ventricular myocytes.

Authors:  G J Amos; E Wettwer; F Metzger; Q Li; H M Himmel; U Ravens
Journal:  J Physiol       Date:  1996-02-15       Impact factor: 5.182

Review 5.  Mechanisms and Drug Development in Atrial Fibrillation.

Authors:  David Calvo; David Filgueiras-Rama; José Jalife
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

6.  Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.

Authors:  Charles Antzelevitch; Alexander Burashnikov
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 7.  Atrial-selective sodium channel blockers: do they exist?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  J Cardiovasc Pharmacol       Date:  2008-08       Impact factor: 3.105

Review 8.  New pharmacological strategies for the treatment of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

9.  Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.

Authors:  Alexander Burashnikov; José M Di Diego; Andrew C Zygmunt; Luiz Belardinelli; Charles Antzelevitch
Journal:  Circulation       Date:  2007-09-04       Impact factor: 29.690

10.  Characterization of multiple ion channels in cultured human cardiac fibroblasts.

Authors:  Gui-Rong Li; Hai-Ying Sun; Jing-Bo Chen; Yuan Zhou; Hung-Fat Tse; Chu-Pak Lau
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.